Showing results (811-820 of 818) with videos related to
Sort By:
Pageof 82
You have reached the last page of results.This site can display upto 818 results.
Blood Advances|December 7, 2019
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settingsAnn T Farrell, Julie Panepinto, Ankit A Desai, et al.The Lancet. Haematology|March 30, 2024
Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trialMark T Gladwin, Victor R Gordeuk, Payal C Desai, et al.Nature Communications|January 13, 2026
CD39 polymorphism enables lung thrombosis in sickle cell diseaseTomasz Brzoska, Tomasz W Kaminski, Omika Katoch, et al.Haematologica|September 18, 2012
The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and EuropeMehdi Nouraie, Janet S Lee, Yingze Zhang, et al.Pediatric Pulmonology|December 17, 2008
Strategic plan for pediatric respiratory diseases research: an NHLBI working group reportSteve Abman, Alan Jobe, Victor Chernick, et al.Pharmaceutics|February 24, 2024
Antiviral Action against SARS-CoV-2 of a Synthetic Peptide Based on a Novel Defensin Present in the Transcriptome of the Fire Salamander (Salamandra salamandra)Ana Luisa A N Barros, Vladimir C Silva, Atvaldo F Ribeiro-Junior, et al.Annals of the American Thoracic Society|August 31, 2019
Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop ReportA Parker Ruhl, S Christy Sadreameli, Julian L Allen, et al.JAMA|April 20, 2021
Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical TrialJames F Casella, Bruce A Barton, Julie Kanter, et al.Pageof 82